A project of the Fondation RES
Systemic Juvenile Idiopathic Arthritis (sJIA) and adult onset still disease(AOSD)
SJIA is a systemic inflammatory condition, with both systemic and joint involvement, classified within the spectrum of juvenile idiopathic arthritis (JIA). However, it is believed to be a distinct disease entity with more similarities with autoinflammatory disorders. AOSD is a heterogeneous entity characterized by 4 cardinal features: marked fever, evanescent rash, arthralgia or arthritis, and neutrophilic leukocytosis in the absence of infection, rheumatoid factor and ANA.
Who we are
We are a group of worldwide rheumatologists pediatricians specialized in
Systemic Juvenile Idiopathic Arthritis (sJIA) and adult onset still disease (AOSD)
Katerina Theodoropoulou, CH
WG Group Leader
Charlotte Girard-Guyonvarc'h, CH
WG Science communication officer
Sophie Georgin Lavialle, FR
CliPS Vice Chair & Vice WG Leader
Francisca Aguiar, PT
WG Repository officer
Sohad Hashad, LY
WG Grant awarding officer
Karima ABBACI-Daghor, DZ
WG Registry officer
How to participate ?
You are interested in CliPS ?
You can get involved at 2 different levels :
Answer our questionnaires
Share your experience through the CliPS questionnaire.
We have 5 questionnaires, each of them treats a different medical condition :
-
Lupus Nephritis
-
Kawasaki and IgA Vasculitis
-
sJIA
-
PFAPA/SURF
-
Biologics in monogenic auto inflammatory disease
Join our Working Groups
The CliPS project receives COST European funding for all networking and dissemination activities for the next 4 years.
Join one of our Working Groups (for 1 of the 5 medical conditions) and get involved in:
-
The data analysis process,
-
The creation of the repository and
-
In the dissemination of the project
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
https://www.cost.eu/actions/CA21168/
